The purpose of this pilot study is to use a pre surgical intervention model to evaluate the
biologic effects of metformin in women with newly diagnosed early invasive breast cancer.
Metformin is a drug commonly used to treat patients with diabetes. This model will be used to
evaluate the effects of metformin.